Human enhancer of invasion, clone 10 (HEI10) (CCNB1IP1) was first described as a RING-finger family ubiquitin ligase that regulates cell cycle by interacting with cyclin B and promoting its degradation. Subsequently, other studies suggested specific upregulation of HEI10 in metastatic melanoma and demonstrated direct interaction between HEI10 and the tumor suppressor Merlin, encoded by the neurofibromatosis 2 gene. These and other results led us to hypothesize that HEI10 also influences the processes of cell migration and metastasis. We here show that cells with depleted HEI10 both migrate more rapidly and invade more effectively than control cells. HEI10 depletion post-transcriptionally increases the expression of a group of promotility regulatory proteins including p130Cas, paxillin, Cdk1 and cyclin B2, but excluding Merlin. Among these, only inhibition of Cdk1/ cyclin B activity specifically reversed the motility and invasion of HEI10-depleted cells. Finally, HEI10 is abundantly transcribed in many human tissues, and particularly abundant in some tumor cell lines, suggesting that it may be commonly involved in coordinating cell cycle with cell migration and invasion.
Introduction
Development of cancer requires multiple changes in the regulation of cell physiology. As defined by Hanahan and Weinberg (2000) , to form an aggressive tumor, a cell must autonomously provide growth signals, become insensitive to growth-inhibitory signals, inactivate proapoptotic pathways, acquire a limitless replicative potential, promote angiogenesis and become able to invade tissues and metastasize to distant sites. Some tumor suppressors and oncogenes function specifically in one of these defined areas: for example, mutations in Bcl2 predominantly affect apoptosis (Fesik, 2005) . In other cases, the action of tumor-associated proteins is more complex. For example, mutation of Ras affects not only cell proliferation, but also apoptosis and metastasis, because of the central place Ras occupies in essential cell signaling pathways. Indeed, proteomics and systems biology analyses are now finding that many important signaling proteins interact with a diverse set of partners in different functional spheres (Schwikowski et al., 2000; Rual et al., 2005) , complicating simple characterization of their function.
Human enhancer of invasion, clone 10 (HEI10) was first identified by our group in a functional genomic screen for novel human genes that influenced cell cycle progression and/or polarization (Toby et al., 2003) . Overexpression of HEI10 causes yeast to extend the G2 phase of cell cycle and to become hyperpolarized. Our subsequent characterization of overexpressed HEI10 revealed that this protein interacts with cyclin B and that high levels of HEI10 promote the degradation of cyclin B in vertebrate cells and of the cyclin B ortholog Clb2p in yeast. These activities of HEI10 depended on the integrity of the HEI10 RING domain. A RING domain is a common feature of ubiquitin ligases (Jackson et al., 2000) , and HEI10 was found to both interact with a ubiquitin-conjugating enzyme and to induce its own auto-ubiquitination in a purified in vitro system. On the basis of these data, a first model for HEI10 was as regulator of the rate of cyclin B accumulation during G2.
Other studies have suggested a more complicated function for HEI10. Mine et al. (2001) identified HEI10 as a chimeric protein fused to HMG1C, in a translocation found in uterine leiomyoma, raising the possibility that aberrant HEI10 action may contribute to cancer development. A study of mRNA transcripts elevated in melanoma suggested that HEI10 is highly upregulated, specifically in melanoma metastases (Smith et al., 2004) . Gronholm et al. (2006) have recently identified HEI10 as a physical interactor with the Merlin tumor-suppressor protein. This last identification is particularly intriguing, as Merlin, encoded by the neurofibromatosis 2 (NF2) gene, regulates both cell proliferation and migration (Evans et al., 2000; Xiao et al., 2005) . Further, the expression of HEI10 and Merlin are interdependent, and the proteins colocalize in some phases of cell cycle, with a subpopulation of HEI10 located at cortical actin at the cell periphery (Gronholm et al., 2006) . Together, these studies caused us to hypothesize that HEI10 not only regulates cell cycle, but also influences cell migration and invasion.
In this report, we demonstrate that HEI10 is required for cell cycle progression. In addition, HEI10 regulates both cell migration and invasion and governs the steadystate level of several proteins known to promote actively these processes. However, contrary to expectation, HEI10 negatively regulates cell motility, in a mechanism involving post-transcriptional downregulation of p130Cas, cyclin B and Cdk1. Coupled with an analysis of HEI10 mRNA expression in primary cells, cell lines and tumors, our data in sum indicate that HEI10 can both promote and inhibit cancerous cell growth and serves as a novel node-connecting cell cycle and cell migration.
Results

HEI10 is required for cell proliferation
To analyse HEI10 function, we used two separate HEI10-targeted siRNAs for all experiments. Following siRNA transfection of U20S or MCF7 cells, HEI10 levels were typically reduced by B75% for up to 5 days (Figure 1a-c) . As HEI10 binds and promotes degradation of cyclin B (Toby et al., 2003) , we first assessed whether HEI10 depletion induced proliferation defects by measuring cell doubling. For the first 2 days after transfection, both HEI10-depleted and control cells appeared similar (not shown). By 3 days following siRNA transfection, numbers of HEI10-depleted cells had not significantly increased in reference to seeding densities, although cells appeared morphologically normal (Figure 1d ). By 4-5 days post-transfection, the number of HEI10 siRNA-transfected cells was consistently reduced below the number of cells seeded for assay (Figure 1d ). Fluorescence-activated cell sorting (FACS) analysis (Figure 1e ) indicated that although the cell cycle profile of HEI10-depleted cells remained similar to that of controls for 3 days, by 4-5 days after transfection the G2 cell cycle compartment was proportionally reduced and the population contained many floating cells.
To establish whether the effect of HEI10 depletion was in restriction of cell cycle, we investigated cell death of HEI10-depleted versus control cells by measuring the relative rates of the appearance of pycnotic nuclei (Figure 1f ), the cell death-associated mobilization of phospholipids ( Figure 1g ) and caspase-dependent cleavage of poly(ADP-ribose) polymerase (PARP) or gelsolin (not shown). On the basis of all these measures, rate of apoptosis was not selectively enhanced by HEI10 depletion. These studies demonstrated that HEI10 is predominantly required for cell proliferation. The earlier 2-3 day time points were consistently used for subsequent studies of HEI10.
Depletion of HEI10 promotes cell motility, invasion through Matrigel and cell spreading To assess whether HEI10 has a role in cell migration, HEI10-or control-depleted cells were seeded into the top of a Boyden chamber and the number of cells migrating through the pores over 24 h was scored (Figure 2a) . HEI10 depletion increased cell migration 2.6-to 4.4-fold versus control-depleted cells. In a second approach, siRNA-transfected cells were allowed to form a monolayer over 48 h. The monolayer was scratched and live cell imaging was used to track the closure of the scratch over the next 24 h (Figure 2b and c) . This assay also indicated faster migration of HEI10-depleted cells, with the greatest motility increase occurring at the earlier times of observation, whereas many cells with depleted HEI10 began to detach at later time points.
To assess the role of HEI10 in invasion, a Boyden chamber approach was again used to compare the relative movement of HEI10-versus control-depleted cells through Matrigel-coated versus uncoated filters ( Figure 3a) . About 57-71% more HEI10-depleted versus control-depleted U2OS cells invaded through Matrigel. To assess the role of HEI10 in cell spreading, HEI10-or control-depleted cells were trypsinized 48 h after transfection and the extent of reattachment to cell culture plastic or poly-L-lysine was observed for the following 24 h (Figure 3b and c, and not shown). Although HEI10-depleted cells consistently spread to a greater extent than controls at later time points on either support, the degree of increase was only marginally and statistically significant. Moreover, the rate of appearance of indicators of cell attachment, such as accumulation of proteins such as paxillin at focal adhesions (Figure 3c ), was similar in HEI10-and control-depleted cells. Together, these results suggested that HEI10 had a limited role in the initial spreading process, but a significant role in cell migration and invasion.
HEI10 depletion modulates the expression and activity of promotility regulatory proteins HEI10 is a ubiquitin ligase. We first hypothesized that HEI10 depletion might cause the upregulation of promotility proteins such as Merlin and other cytoskeletally localized proteins with which Merlin can associate, such as focal adhesion kinase (FAK) (James et al., 2004) . However, HEI10 depletion did not affect steadystate levels of Merlin or FAK (Figure 4a and b). This finding was consistent with the prediction of Gronholm et al. (2006) , which placed HEI10 downstream of Merlin in cell signaling cascades. In contrast, the phosphorylation of FAK on Y 397 , associated with kinase activation (Ruest et al., 2000) and increased cellular migration, was consistently elevated by 4-to 6-fold following HEI10 depletion ( Figure 4b ). FAK is not only regulated by Merlin (Poulikakos et al., 2006) , but also by association with focal-adhesion localized signaling proteins such as p130Cas (Brabek et al., 2005) and paxillin (Wade and Vande Pol, 2006) . Total levels of paxillin and p130Cas were consistently elevated by 5-to 6-fold in HEI10-versus control-depleted cells (Figure 4c and d) .
The levels of Y 165 -phosphorylated (activated)-p130Cas (Bouton and Burnham, 1997) increased proportionally to the levels of total p130Cas ( Figure 4c ).
We assessed additional motility regulators including Cdc42, Pak1, ROCK1 and ROCK2 (Klemke et al., 1998; Zhao et al., 2000; Kaempchen et al., 2003; Worthylake and Burridge, 2003; Hirokawa et al., 2004; Xiao et al., 2005) (Figure 4e-g ). HEI10 depletion had no effect on the steady-state levels of Cdc42 or Pak1 and significantly decreased the levels of ROCK1 and ROCK2. In sum, these data indicated that HEI10 depletion did not promiscuously upregulate expression of migration regulatory proteins. Given their upregulation, p130Cas and paxillin were the best candidates for direct targets of HEI10-dependent proteolysis. However, to date, efforts to coimmunoprecipitate HEI10 with these proteins have been unsuccessful (results not shown). Hence, HEI10 regulation of p130Cas, FAK and other proteins may be indirect, reflecting propagation of promigratory signals from a separate source.
Post-transcriptional upregulation of B-type cyclins and Cdk1 by HEI10 depletion promotes migration
We have demonstrated previously that HEI10 interacts directly with B-type cyclins (Toby et al., 2003). The recent description of a Cdk1/cyclin B2-dependent promotility pathway (Juliano, 2003; Manes et al., 2003) suggested an alternative direct means by which HEI10 depletion may influence cell migration. Indeed, steady-state levels of cdk1, cyclinB1 and cyclin B2 were elevated 3-fold, 4-to 7-fold and 4-fold, respectively, in HEI10-depleted cells compared with control cells (Figure 5a and b). Elevated levels of each of these proteins were also clearly visible by immunofluorescence of HEI10-depleted or control cells ( Figure 5c , and results not shown).
To further probe the mechanism of HEI10 control of the expression of promigratory factors, cells were depleted for 48 h with siRNA directed to HEI10 or scrambled control, then total RNA was harvested and analysed by quantitative real time-polymerase chain reaction (RT-PCR). As shown in Figure 5d , the transcript levels of p130Cas, B-type cyclins and Cdk1 were essentially unaffected by HEI10 depletion, indicating that HEI10 regulation of these proteins was posttranscriptional. At least for cyclin B/Cdk1, this most probably reflects loss of direct HEI10-dependent ubiquitination and proteolysis. 
Inhibition of Cdk1 specifically limits HEI10-dependent migration and invasion
To establish which signaling pathways were particularly important for HEI10-dependent motility, we used small molecule inhibitors and/or siRNAs to inhibit specific proteins or pathways in HEI10-or control-depleted cells. We have found that roscovitine, a specific inhibitor of Cdk1 activity, selectively and strongly inhibits the migration and invasion of HEI10-depleted cells, whereas having no effect on migration of control cells (Figure 5e and f). Indeed, roscovitine essentially eliminates the increased invasion associated with HEI10-depletion. Supporting these results, Cdk1 from HEI10-depleted cells was substantially more active than that found in control cells ( Figure 5g) ; roscovitine completely inhibited the enhanced Cdk1 activity. These results are congruent with and may be explained by the observation that B-cyclins are much more abundant following HEI10 depletion, driving Cdk1 activity (Figure 5a and b) . We have used a similar approach to probe the p130Cas/FAK/Src signaling pathway, using the Src kinase inhibitor PP2 and a strategy of siRNA codepletion (e.g., of HEI10 and p130Cas). Although these manipulations have influenced cell migration overall, no experiment using this strategy has inhibited migration in a manner that is specific for HEI10-depleted cells (results not shown).
In vivo expression of HEI10
Ideally, these functional analyses would be balanced with reciprocal studies analysing the consequences of HEI10 overexpression. However, as we have reported previously (Toby et al., 2003) , even moderate overexpression of HEI10 in mammalian cells leads to accumulation of most of the protein in apparently aggregated structures associated with the Golgi compartment, making interpretation of such an experiment problematic. In lieu of being able to readily overexpress HEI10, we have studied the distribution of HEI10 in different tissues and cell types, to determine if HEI10 expression levels suggest a characteristic profile of migratory or invasive behavior (Supplementary Figure  S1) . Particularly as elevated HEI10 mRNA expression has been suggested by one group to correlate with aggressive melanomas (Smith et al., 2004) , this seemed an important test. However, based on our current data, it is not possible to correlate significantly HEI10 mRNA expression with a specific cell lineage (Supplementary Figure S1a) or degree of cancer aggressiveness (Supplementary Figure S1b and c) . Rather, HEI10 mRNA is 
Discussion
These data indicate that HEI10 negatively regulates cellular spreading, motility and invasion, but is required for cellular proliferation. Loss of HEI10 expression post-transcriptionally increased the total levels or activation of a number of proteins described previously as promoting cell motility, including p130Cas, paxillin, FAK, B-type cyclins and Cdk1. However, only inhibition of Cdk1/cycB activity selectively reduced HEI10-associated enhancement of migration and invasion, as opposed to generally influencing these processes. We have demonstrated previously direct interaction between HEI10 and B-type cyclins. The simplest explanation for these results is that HEI10 depletion specifically stabilizes Cdk1/cyclin B complexes from HEI10-dependent proteolysis. This triggers promigratory signaling changes that propagate through the cell motility protein interaction network, ultimately stabilizing p130cas and paxillin (and potentially other proteins) and thereby activating FAK. Further supporting this interpretation, the study which first identified the role of CycB/Cdk1 in cell migration (Manes et al., 2003) described a phenotype for overexpression of CycB/Cdk1 very similar to that reported here for HEI10 depletion.
HEI10 directly interacts with Merlin (NF2) (Gronholm et al., 2006) . In cells induced to express Merlin, HEI10 moved from the nucleus to the cytoplasm in NF2 À/À cells, HEI10 concentrated in the nucleus. Merlin acts to inhibit cell growth and proliferation; cells lacking Merlin are hyper-proliferative and migrate more actively. A model incorporating these observations with the new data presented here would postulate that in cells lacking Merlin, the concentration of HEI10 in the nucleus reduces the ability of HEI10 to interact with and downregulate extranuclear proteins affecting migration in interphase, these proteins would include the B-type cyclins (Draviam et al., 2001) . This may in part mediate the increased motility of NF2-deficient cells (Evans et al., 2000) . In contrast, neither the Gronholm study nor our work here suggests that HEI10 influences the expression of Merlin, assigning HEI10 a role as a potential effector of this tumor suppressor.
We do not observe a striking variation in HEI10 mRNA expression between melanomas of different stages or between melanomas and normal melanocyte cell lines (Supplementary Figure S1) . Interestingly, examining tumor cell lines derived from different tissues of origin, although central nervous system and ovarian cell lines similarly show relatively homogenous levels of HEI10 (o2-fold variation), breast and lung cancer cell lines show a much greater range of HEI10 expression. 
HEI10 inhibits cell invasion MK Singh et al
There appeared to be two distinct groups of breast cell lines, separated by B6-8-fold difference in HEI10 expression; however, highly metastatic cell lines were found in both low and high expressor groups (e.g., MDA-MB-231, and HS-578 T). A recent paper has identified amplification of sequences localized to 14q11.2 as characteristic of specific subtypes of lung cancer (Nymark et al., 2006) ; HEI10 localizes to this region of chromosome 14, and it will be of interest to see if HEI10 is specifically targeted by such genetic changes. Given the complex role of HEI10 in regulating cell growth, it is likely to be difficult to identify a straightforward functional relationship between expression levels and tumor aggressiveness. Nevertheless, based on the evolving delineation of interactions between HEI10, cyclin B/Cdk1 and Merlin, HEI10 clearly is positioned to influence both cell cycle and migratory properties of NF2-mutant cells, and HEI10 status may modulate the severity of disease in families with hereditary NF, and influence other cancers.
Materials and methods
Cells and cell lines
Human osteosarcoma cells (U2OS) and human breast adenocarcinoma cell lines (MCF7) (American Type Culture Collection) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics.
siRNAs and inhibitors Two HEI10-directed RNA oligonucleotide duplexes and a scrambled siRNA control were used (from Dharmacon, Lafayette, CO, USA; sequences on request). For each experiment, after transfection of siRNAs (using Oligofectamine, Invitrogen, Carlsbad, CA, USA) the degree of depletion of target mRNA was determined by reverse transcription RT quantitative PCR (RT-qPCR) or by Western blotting. Depletion was typically between 70 and 90%; experimental runs in which depletion o65% was observed were discarded. To inhibit Cdk1 kinase, cells were treated with 50 mM roscovotine (CALBIOCHEM, EMD Biosciences, San Diego, CA, USA), which was added to the medium at the time of seeding cells into Boyden chambers.
Western blots, immunoprecipitation, kinase and apoptosis assays Standard protocols were used for preparation of cell lysates for western blotting and immunoprecipitations. Primary antibodies used in this study for western blotting and immunofluorescence included mouse monoclonal antibodies to paxillin, cdc42, p130cas, FAK, cyclin B1, PARP, gelsolin (BD Biosciences, San Jose, CA, USA), b-actin (Sigma, St Louis, MO, USA) and Cdk1 (Oncogene Research Products, San Diego, CA, USA) and rabbit polyclonal antibodies to phospho-p130cas Y165 , PAK1 (both from Cell Signaling, Danvers, MA, USA), cyclin B2, Rock1, Rock2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), HEI10 (Toby et al., 2003) and FAK Y397 (Covance, Berkeley, CA, USA). Secondary anti-mouse and anti-rabbit HRP-conjugated antibodies were from Amersham (Piscataway, NJ, USA). To quantify Western blot data, densitometric analysis of enhanced chemoluminescence (ECL)-exposed blots was performed using NIH ImageJ (version 1.240) software. To assess Cdk1 activity in HEI10-depleted and/or roscovitine-treated cells, protein lysates from siRNA-treated cells were immunoprecipitated with Cdk1-directed antibody, followed by in vitro kinase assay using a Cdk1 Kinase Assay Kit (Upstate, Charlottesville, VA, USA), as per manufacturer's instructions. The APOPercentage apoptosis assay kit was from Biocolor, Ltd (Belfast, Northern Ireland, UK). Pretreatment with 5 mM cisplatin for 24 h was used as a positive control to score pycnotic nuclei.
Microscopy
For immunofluorescence, cells growing on coverslips were fixed with 4% paraformaldehyde, permeabilized, blocked and incubated with antibodies using standard protocols. Secondary antibodies (including anti-mouse Alexa-488, anti-rabbit Alexa488, anti-mouse Alexa-568, anti-rabbit Alexa568) and 4,6-diamidino-2-phenylindole (DAPI) were from Invitrogen, and Hoechst 33342 from Molecular Probes (Carlsbad, CA, USA). Fluorescence microscopy was performed using a Nikon Eclipse TE 2000 microscope (Nikon Corporation Co. Ltd, Kanagawa, Japan).
To measure cell spreading, cells were first transfected with scrambled or HEI10-targeted siRNAs. After 48 h, cells were detached by incubation in PBS þ 5 mM ethylenediaminetetraacetic acid for 15 min at 371C, then re-plated onto either uncoated glass coverslips or poly-L-lysine coated cover slips (Fisher, Pittsburgh, PA, USA) in DMEM þ 10% FBS. Cells were fixed with 4% paraformaldehyde at indicated time points and stained with anti-paxillin to visualize cell boundaries. In each group, cell area measurements were determined for B100 cells using Metamorph imaging software. For Boyden chambers, migration analysis was performed according to the manufacturer's (Becton Dickinson, San Jose, CA, USA) protocol 48 h after treatment of cells with siRNA. In parallel, as a control for changes in cell proliferation related to HEI10 depletion (see Figure 1) , total cell proliferation of cells comparably treated with siRNAs was established by daily calculation of cell numbers over the course of the assay. Migration values were corrected based on proliferation index of siRNA-treated cells, that is, made proportionate to the number of cells in the population at 3 days post-transfection. For wound-healing assays, cells were transfected with siRNAs then plated at a density suitable to cause confluence after 48 h. Wounds in the cell monolayer were made using a pipette tip and then cells were maintained at 371C in a stage incubator on top of a Nikon Eclipse E800 inverted microscope (Carl Zeiss, Thornwood, NY, USA). Images were acquired for 24 h with a Quantix-cooled charge-coupled device camera (Roper Scientific, Trenton, NJ, USA), and analysed using Metamorph.
All calculations of statistical significance were made using the GraphPad InStat software package (San Diego, CA, USA) and STATA software (Stata Corps, TX, USA). Approaches included unpaired t-test (with Welch correction), the MannWhitney test and multiple linear regression analysis.
RT-qPCR
Contaminating DNA from RNA preparations was removed using TURBO DNA-free (Ambion, Austin, TX, USA). RNA from cell lines was quantified using the Agilent 2100 BioAnalyzer in combination with a RNA 6000 Nano LabChip. RNA was reverse-transcribed using M-MLV reverse transcriptase (Ambion) and a mixture of anchored oligo-dT and random decamers. 5 0 -Nuclease assays using Taqman chemistry were run on a 7900 HT sequence detection system (Applied Biosystems, Foster City, CA, USA). The sequences of the primers and probes used and assay details are provided in Supplementary Table S1 .
